Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amy Zaremba Rabourn Insider Profile
4 Followers
Amy Zaremba Rabourn, SVP of Finance at Ocuphire Pharma, holds 82.66K shares in Ocuphire Pharma (Ticker: OCUP).
Amy Zaremba Rabourn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Amy Zaremba Rabourn's holdings
Insider Roles
SVP of Finance
Roles that Amy Zaremba Rabourn holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Amy Zaremba Rabourn
Amy Zaremba Rabourn's Trading History
List of latest transactions for each holding click on a transaction to see Amy Zaremba Rabourn's performance on stock
You May Also Like
Amy Zaremba Rabourn insider profile FAQ
What is the percentage of profitable transactions made by Amy Zaremba Rabourn?
The percentage of profitable transactions made by Amy Zaremba Rabourn is ―.
What is the average return per transaction made by Amy Zaremba Rabourn?
The average return per transaction made by Amy Zaremba Rabourn is ―.
What stocks does Amy Zaremba Rabourn hold?
Amy Zaremba Rabourn holds: OCUP stocks.
What was Amy Zaremba Rabourn’s latest transaction?
Amy Zaremba Rabourn latest transaction was an Uninformative Buy of ―.
What was Amy Zaremba Rabourn's most profitable transaction?
Amy Zaremba Rabourn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Amy Zaremba Rabourn's role in Ocuphire Pharma?
Amy Zaremba Rabourn's role in Ocuphire Pharma is SVP of Finance.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.